Decision COP 14/19
Synthetic biology
3. Agrees that broad and regular horizon scanning, monitoring and assessing of the most recent technological developments is needed for reviewing new information regarding the potential positive and potential negative impacts of synthetic biology vis-à-vis the three objectives of the Convention and those of the Cartagena Protocol and Nagoya Protocol;
5. Also recognizes that developments arising from research and development in the field of synthetic biology may pose challenges to the ability of some countries, especially developing countries, in particular those with limited experience or resources, to assess the full range of applications and potential impacts of synthetic biology on the three objectives of the Convention;
9. Recognizes that, as there could be potential adverse effects arising from organisms containing engineered gene drives, before these organisms are considered for release into the environment, research and analysis are needed, and specific guidance may be useful, to support case-by-case risk assessment;
10. Notes the conclusions of the Ad Hoc Technical Expert Group on Synthetic Biology that, given the current uncertainties regarding engineered gene drives, the free, prior and informed consent of indigenous peoples and local communities might be warranted when considering the possible release of organisms containing engineered gene drives that may impact their traditional knowledge, innovation, practices, livelihood and use of land and water;
11. Calls upon Parties and other Governments, taking into account the current uncertainties regarding engineered gene drives, to apply a precautionary approach, in accordance with the objectives of the Convention, and also calls upon Parties and other Governments to only consider introducing organisms containing engineered gene drives into the environment, including for experimental releases and research and development purposes, when:
(c) Where appropriate, the “prior and informed consent”, the “free, prior and informed consent” or “approval and involvement” of potentially affected indigenous peoples and local communities is sought or obtained, where applicable in accordance with national circumstances and legislation;
12. Calls upon Parties, other Governments and relevant organizations to continue to develop or implement, as appropriate, measures to prevent or minimize potential adverse effects arising from exposing the environment to organisms, components and products of synthetic biology in contained use, including measures for detection, identification and monitoring, in accordance with domestic circumstances or internationally agreed guidelines, as appropriate, with special consideration to the centres of origin and genetic diversity;
13. Also calls upon Parties, other Governments and relevant organizations to continue to disseminate information and share, especially through the clearing-house mechanisms of the Convention and the Biosafety Clearing-House, their experiences on scientific assessments of the potential benefits and potential adverse impacts of synthetic biology to biological diversity, including, inter alia, that of specific applications of organisms containing engineered gene drives, and from the use of living modified organisms that have been released into the environment;
15. Also decides to extend the Open-ended Online Forum on Synthetic Biology, taking into account the work on risk assessment under the Cartagena Protocol, to support the deliberations of the Ad Hoc Technical Expert Group on Synthetic Biology, and invites Parties, other Governments, indigenous peoples and local communities and relevant organizations to continue to nominate experts to take part in the Online Forum on Synthetic Biology;
16. Invites Parties, other Governments, indigenous peoples and local communities, and relevant organizations to provide the Executive Secretary with relevant information related to paragraphs (a) to (d) of the annex in order to contribute to the work of the Ad Hoc Technical Expert Group;
17. Requests the Executive Secretary, subject to the availability of resources:
(b) To facilitate the work of the Ad Hoc Technical Expert Group on Synthetic Biology by, among other things, collecting and synthesizing and arranging for peer review of relevant information, and convening at least one face-to-face meeting;
(c) To update the Technical Series on Synthetic Biology for consideration by the Subsidiary Body on Scientific, Technical and Technological Advice based on the peer review of scientific information and other relevant information;
(d) To further pursue cooperation with other organizations, conventions and initiatives, including academic and research institutions, from all regions, on issues related to synthetic biology, including the exchange of experiences and information;
(e) To explore ways to facilitate, promote and support capacity-building and knowledge-sharing regarding synthetic biology, taking into account the needs of Parties and of indigenous peoples and local communities, including through necessary funding, and the co-design of information and training materials in the official languages of the United Nations and, where possible, in local languages;
(f) To collaborate and convene discussions, including through the Network of Laboratories for the Detection and Identification of Living Modified Organisms, for sharing experiences on the detection, identification and monitoring of organisms, components and products of synthetic biology, and to continue inviting laboratories, including analytical laboratories, to join the Network;
(g) To ensure the full and effective participation of indigenous peoples and local communities in the discussions and in the work on synthetic biology under the Convention, in accordance with decision X/40;
18. Requests the Subsidiary Body on Scientific, Technical and Technological Advice:
(b) To note the preliminary analysis done by the Executive Secretary and to consider further analyses and advice from the Ad Hoc Technical Expert Group on Synthetic Biology of the relationship between synthetic biology and the criteria set out in decision IX/29, paragraph 12, in order to contribute to the completion of the analysis requested in decision XII/24, paragraph 2;
- Body
- Conference of the Parties (COP)
- Meeting
- COP-1417 - 29 November, 2018Sharm El-Sheikh, Egypt
- Actors
- 34 8 Parties 8 Other Government(s) 4 Relevant organizations 2 Indigenous peoples and local communities 8 Executive Secretary of the Convention on Biological Diversity 4 SBSTTA
- AICHI targets
-
18




- Subjects
- 75 31 Cartagena Protocol on Biosafety 31 Synthetic Biology 2 Clearing-House Mechanism 2 Capacity-building and Development 2 Indigenous peoples and local communities 1 Traditional Knowledge, Innovations and Practices 5 Subsidiary Body on Scientific, Technical and Technological Advice (SBSTTA) 1 Conference of the Parties
- Decision document
- 14/19Synthetic biology
- Outcomes
- 0061802 November, 2021Online00625227 April, 2022OnlineCP-MOP-107 - 19 December, 2022Montreal, CanadaSBSTTA-2414 - 29 March, 2022Geneva, SwitzerlandSBSTTA-OM-2021-0228 January, 2021OnlineSYNBIO-AHTEG-2019-014 - 7 June, 2019Montreal, CanadaSYNBIO-WS-2025-013 - 7 November, 2025Isle of Vilm, GermanyCBD/CP/MOP/10/INF/5CBD/SBSTTA/24/4/REV1CBD/SBSTTA/24/INF/19CBD/SYNBIO/AHTEG/2019/1/3CBD/SYNBIO/AHTEG/2019/1/INF/1CBD/SYNBIO/AHTEG/2019/1/INF/2CBD/SYNBIO/AHTEG/2019/1/INF/3CBD/SYNBIO/AHTEG/2019/1/INF/4CBD/SYNBIO/WS/2025/1/2
- Related documents
- CBD/SYNBIO/AHTEG/2017/1/3CBD/SYNBIO/AHTEG/2019/1/2CBD/SYNBIO/AHTEG/2019/1/3CBD/SYNBIO/AHTEG/2019/1/INF/1CBD/SYNBIO/AHTEG/2019/1/INF/2
- Related decisions / recommendations